USA law protects Americans from discrimination in health insurance and employment with the
Genetic Information Nondiscrimination Act (GINA) of 2008.
NIH – National Human Genome Research Institute: an overview and resources regarding the Genetic Information Nondiscrimination Act of 2008.
MORL provides dependable, high quality genetic testing and interpretative services within an academic setting.
Molecular Otolaryngology and Renal Research Laboratories (MORL) are recognized nationally and internationally for their expertise in the area of complement-mediated renal diseases and as leaders in genetic testing for deaf and hard-of-hearing persons.
Associated with the Carver College of Medicine at the University of Iowa, our Clinical Diagnostics Division provides functional testing of the complement cascade and genetic screening of all genes implicated in two rare kidney diseases: atypical Hemolytic Uremic Syndrome (aHUS) and C3 glomerulopathy (C3G). C3G includes Dense Deposit Disease (DDD, previously known as Membranoproliferative Glomerulonephritis Type 2 or MPGNII) and C3 glomerulonephritis (C3GN). The Clinical Diagnostic Division also offers OtoSCOPE®, the first truly comprehensive genetic test for hereditary hearing loss, including Usher syndrome and Pendred syndrome
. Final reports are issued after a multidisciplinary meeting to discuss results in the context of any clinical data that has been provided.
Visit the MORL website at http://www.healthcare.uiowa.edu/labs/morl/index.htm
NEW! aHUS Biomarker – Longitudinal Study
announced Aug. 2015 by MORL, the University of Iowa. Click HERE for details, and contact them at
Molecular Otolaryngology and Renal Research Laboratories (MORL) is a Joint Commission-approved CLIA-accredited diagnostic laboratory offering specialized assays of the complement system, genetic testing and clinical relevant interpretation services. For More Information Contact:
Dr. RICHARD JH SMITH- Ph: (319)356-3612 E: email@example.com MORL Ph: (319)335-6623
FMI about MORL Watch the Video
The Rare Renal Disease and Renal Genetics Clinic at the University of Iowa, at http://www.uihealthcare.org/clinic.aspx?id=20590 serves as a national referral center by providing evaluation and management services for children and adults with membranoproliferative glomerulonephritis type I, atypical hemolytic uremic syndrome, dense deposit disease and C3 glomerulonephritis, in addition to inherited renal diseases such as Fabry’s disease, nephronophthisis, polycystic kidney disease and congenital diseases of the kidney.
The Atypical HUS Center of Excellence at the University of Iowa at http://www.uiahuscenter.org/ combines both outreach and education efforts with a strong aHUS research mission and partners with The Foundation for Children with Atypical HUS to deliver full service care to aHUS patients and families alike.
For more information about DDD visit http://www.healthcare.uiowa.edu/kidneeds/
aHUS Outreach and Education initiatives are provided by The Foundation for Children with Atypical HUS for patients, families, and medical providers. For more information about aHUS